TY - JOUR
T1 - Novel, computational IgE-clustering in a population-based cross-sectional study
T2 - Mapping the allergy burden
AU - Czolk, Rebecca
AU - Ruiz-Castell, Maria
AU - Hunewald, Oliver
AU - Wanniang, Naphisabet
AU - Le Coroller, Gwenaëlle
AU - Hilger, Christiane
AU - Vaillant, Michel
AU - Fagherazzi, Guy
AU - Morel-Codreanu, Françoise
AU - Ollert, Markus
AU - Kuehn, Annette
N1 - Funding Information:
We thank T Scheuermann, LE Roth and T Graf, Luxembourg Institute of Health, for their great technical support. Many thanks to Laboratoires Réunis for providing us with the Phadiatop assay results. We also thank the population of Luxembourg and to all of the EHES‐LUX team who have contributed to this study, especially Couffignal, S., Kuemmerle, A., Dincau, M., Mormont, D., Barre, J., Chioti, A., Delagardelle, C., Michel, G., Schlesser, M., Schmit, J.C., Gantenbein, M., Lieunard, C., Columeau, A., Kiemen, M., Weis, J., Ambroset, G., Billy, A., Larcelet, M., Marcic, D., Gauthier, C., and Leners, B., for their valuable contributions. Supported by the Luxembourg National Research Fund on PRIDE program grant PRIDE17/11823097/MICROH and PRIDE i2TRON PRIDE19/14254520. For the purpose of open access, the author has applied a Creative Commons Attribution 4.0 International (CC BY 4.0) license to any Author Accepted Manuscript version arising from this submission. Supported additionally by the Ministry of Health and the Ministry of Higher Education and Research.
Funding Information:
We thank T Scheuermann, LE Roth and T Graf, Luxembourg Institute of Health, for their great technical support. Many thanks to Laboratoires Réunis for providing us with the Phadiatop assay results. We also thank the population of Luxembourg and to all of the EHES-LUX team who have contributed to this study, especially Couffignal, S., Kuemmerle, A., Dincau, M., Mormont, D., Barre, J., Chioti, A., Delagardelle, C., Michel, G., Schlesser, M., Schmit, J.C., Gantenbein, M., Lieunard, C., Columeau, A., Kiemen, M., Weis, J., Ambroset, G., Billy, A., Larcelet, M., Marcic, D., Gauthier, C., and Leners, B., for their valuable contributions. Supported by the Luxembourg National Research Fund on PRIDE program grant PRIDE17/11823097/MICROH and PRIDE i2TRON PRIDE19/14254520. For the purpose of open access, the author has applied a Creative Commons Attribution 4.0 International (CC BY 4.0) license to any Author Accepted Manuscript version arising from this submission. Supported additionally by the Ministry of Health and the Ministry of Higher Education and Research.
Publisher Copyright:
© 2023 The Authors. Clinical and Translational Allergy published by John Wiley & Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.
PY - 2023/9
Y1 - 2023/9
N2 - Background: Even though the prevalence of allergies is increasing, population-based data are still scarce. As a read-out for chronic inflammatory information, new methods are needed to integrate individual biological measurements and lifestyle parameters to mitigate the consequences and costs of allergic burden for society. Methods: More than 480.000 data points were collected from 1462 Luxembourg adults during the representative, cross-sectional European Health Examination Survey, spanning health and lifestyle reports. Deep IgE-profiles based on unsupervised clustering were correlated with data of the health survey. Findings: 42.6% of the participants reported a physician-diagnosed allergy and 44% were found to be IgE-positive to at least one allergen or extract. The main sensitization sources were tree pollens followed by grass pollens and mites (52.4%, 51.8% and 40.3% of sensitized participants respectively), suggesting seasonal as well as perennial burden. The youngest group of participants (25–34 years old) showed the highest burden of sensitization, with 18.2% of them having IgE to 10 or more allergen groups. Unsupervised clustering revealed that the biggest cluster of 24.4% of participants was also the one with the highest medical need, marked by their multi-sensitization to respiratory sources. Interpretation: Our novel approach to analyzing large biosample datasets together with health information allows the measurement of the chronic inflammatory disease burden in the general population and led to the identification of the most vulnerable groups in need of better medical care.
AB - Background: Even though the prevalence of allergies is increasing, population-based data are still scarce. As a read-out for chronic inflammatory information, new methods are needed to integrate individual biological measurements and lifestyle parameters to mitigate the consequences and costs of allergic burden for society. Methods: More than 480.000 data points were collected from 1462 Luxembourg adults during the representative, cross-sectional European Health Examination Survey, spanning health and lifestyle reports. Deep IgE-profiles based on unsupervised clustering were correlated with data of the health survey. Findings: 42.6% of the participants reported a physician-diagnosed allergy and 44% were found to be IgE-positive to at least one allergen or extract. The main sensitization sources were tree pollens followed by grass pollens and mites (52.4%, 51.8% and 40.3% of sensitized participants respectively), suggesting seasonal as well as perennial burden. The youngest group of participants (25–34 years old) showed the highest burden of sensitization, with 18.2% of them having IgE to 10 or more allergen groups. Unsupervised clustering revealed that the biggest cluster of 24.4% of participants was also the one with the highest medical need, marked by their multi-sensitization to respiratory sources. Interpretation: Our novel approach to analyzing large biosample datasets together with health information allows the measurement of the chronic inflammatory disease burden in the general population and led to the identification of the most vulnerable groups in need of better medical care.
KW - allergy burden
KW - European Health Examination Survey
KW - multiplex IgE-profiles
KW - population-based cross-sectional study
UR - http://www.scopus.com/inward/record.url?scp=85169802693&partnerID=8YFLogxK
UR - https://pubmed.ncbi.nlm.nih.gov/37746799
U2 - 10.1002/clt2.12292
DO - 10.1002/clt2.12292
M3 - Article
C2 - 37746799
SN - 2045-7022
VL - 13
JO - Clinical and Translational Allergy
JF - Clinical and Translational Allergy
IS - 9
M1 - e12292
ER -